How is Ocrevus
given to me? 

Amy, UK


Living with MS since 2018


On Ocrevus since 2021

Amy, UK


Living with MS since 2018


On Ocrevus since 2021

How is Ocrevus given to me?

There are two different ways you can be given the treatment:

I will be receiving Ocrevus by intravenous (IV) infusion

an intravenous (IV) infusion
– where the medicine is administered directly into a vein1

I will be receiving Ocrevus by subcutaneous (SC) injection

a subcutaneous (SC) injection (meaning under the skin)
- where medicine is injected into the skin in your stomach area2

Reporting of side effects


If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Please report suspected side effects to the MHRA through the Yellow Card scheme, via the Yellow card website www.mhra.gov.uk/yellowcard, or the free Yellow Card app available in the Apple App Store or Google Play Store. You should also report side effects to Roche Products Ltd. by emailing the Roche Drug Safety Centre at welwyn.uk_dsc@roche.com or calling +44 (0) 1707 367554. By reporting side effects you can help provide more information on the safety of this medicine.

References:

  1. Ocrevus. Patient Information Leaflet. Ocrevus 300 mg Concentrate for Solution for Infusion Ocrelizumab. Roche Products Limited.
  2. Ocrevus. Patient Information Leaflet. Ocrevus 920 mg Solution for Injection Ocrelizumab. Roche Products Limited.

 

© Roche Products Limited


April 2025 M-GB-00018695